Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Goal disorientation and lack of vision
Biotech

Vistagen fails another phase 3 anxiety trial, spies path forward

With a post hoc analysis showing a nominal statistically significant improvement, the biotech plans to talk to the FDA about a path to approval.
Nick Paul Taylor Jun 30, 2026 9:48am
A ballpoint pen rests on top of a stack of documents ready for signing

Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE

Jun 30, 2026 8:00am
Puerto Rico makes its case as a biotech manufacturing hub

Puerto Rico makes its case as a biotech manufacturing hub

Brought to you by Invest Puerto Rico
Worker bees in hive seen through honeycomb

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
delay

Praxis faces FDA delay, analysts point finger at agency layoffs

Jun 30, 2026 4:13am